Danone Research   Report issue

For profit Phase 2 Phase 3
Founded: Barcelona Spain (1919)
Status: No NME R&D (1919)

Organization Overview

First Clinical Trial
2006
NCT00599859
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Bledina | Danone Asia Pacific Holdings Pte, Ltd. | Danone Institute China Diet Nutrition Research and Communication | Danone Institute International | Danone North America | Danone Nutricia | Danone Nutricia Research | Danone Research | Danone Research Foundation | DANONE RESEARCH, PALAISEAU, FRANCE | Danone Specialized Nutrition Indonesia | Danone Specialized Nutrition (M) Sdn Bhd | PT. Sari Husada | WhiteWave Foods, Inc.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 2)

Coronary Disease (Phase 2)

Diarrhea (Phase 3)

Heart Diseases (Phase 2)

Hypercholesterolemia (Phase 2)

Inflammation (Phase 2)

Myocardial Ischemia (Phase 2)

Vaginal Diseases (Phase 3)

Vaginosis, Bacterial (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 31
  • # of Trial APIs: 24